OpenAlex
PricingAboutJobs
Log inGet started
Work

Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes

HTML PDF

Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetologia
DOI: 10.1007/s00125-007-0633-0
Authors: V. Fonseca, A. Schweizer, D. Albrecht, M. A. Baron, I. Chang, S. Dejager
Institutions: Tulane University, Novartis (Switzerland), Novartis (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: vildagliptin, type 2 diabetes, insulin therapy, DPP-4 inhibitors, glycemic control, HbA1c, hypoglycemia, beta-cell function, glucagon secretion, combination therapy, elderly patients, adverse events, tolerability, uncontrolled diabetes, oral antidiabetic drugs, drug safety and efficacy
SDG: Good health and well-being

Open Access status: bronze

Funders: Tulane University, Novartis Pharmaceuticals Corporation, National Institutes of Health, National Center for Research Resources
Awards: GENERAL CLINICAL RESEARCH CENTER, General Clinical Research Center
OpenAlex ID: W1970406523
FWCI: 28.24
Cites: 18
Cited by: 391
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms